ArticleBritish journal of cancer2014

GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma.

Y Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.